Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
2.74
Feb. 21, 2025 16:00:00- Change 0.04 (1.48148%)
- Volume 67,587
- Today's Open 2.75
- Previous Close 2.7
- Today's High 2.94
- Today's Low 2.6201
- 52 Week High 4.3
- 52 Week Low 1.57